Editas Medicine, Inc. (EDIT) Operating margin 2016–2025
Editas Medicine, Inc. (EDIT) operating margin by fiscal year — reported operating income divided by reported revenue.
-394.9%FY2025 · since FY2016: -1605.6% → -394.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -394.9% | +382.3 pp |
| FY2024 | -777.2% | -560.7 pp |
| FY2023 | -216.6% | +929.7 pp |
| FY2022 | -1146.3% | -390.1 pp |
| FY2021 | -756.1% | -607.5 pp |
| FY2020 | -148.6% | +537.8 pp |
| FY2019 | -686.4% | -330.3 pp |
| FY2018 | -356.1% | +517.5 pp |
| FY2017 | -873.6% | +732.0 pp |
| FY2016 | -1605.6% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice